13.03.2014 • News

Credit Suisse to Advise Hanwha on Possible Dow Chlor-alkali Buy

No potential buyers have yet come forward announcing plans to buy the chlor-alkali business Dow Chemical has said it plans to sell. However, South Korea's Hanwha Chemical said it has engaged Credit Suisse to advise it on possible purchases.

A spokesman for Hanwha told the news agency Reuters its interest is "in the early stages."

As part of plans to "right size" its chlorine footprint to meet its needs in downstream markets, Dow in December 2013 said it would carve out "a significant portion" of its chlorine value chain over the next two years.

The U.S. group said it expected to dispose of assets with $5 billion in annual revenue, including more than 40 production units at 11 sites employing nearly 2,000 people.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.